Vestmark Advisory Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.93M Buy
318,106
+276,646
+667% +$7.37M 0.1% 211
2025
Q4
$1.03M Buy
41,460
+21,660
+109% +$546K 0.01% 784
2025
Q3
$504K Buy
+19,800
New +$489K 0.01% 698
2025
Q2
Sell
-18,724
Closed -$474K 803
2025
Q1
$474K Buy
+18,724
New +$490K 0.01% 523
2024
Q4
Sell
-8,878
Closed -$257K 603
2024
Q3
$257K Buy
+8,878
New +$259K 0.01% 484
2023
Q4
Sell
-37,292
Closed -$1.24M 526
2023
Q3
$1.24M Sell
37,292
-157,193
-81% -$5.56M 0.09% 220
2023
Q2
$7.13M Sell
194,485
-2,578
-1% -$100K 0.27% 87
2023
Q1
$8.04M Buy
197,063
+10,194
+5% +$440K 0.35% 56
2022
Q4
$9.58M Buy
186,869
+6,529
+4% +$313K 0.47% 38
2022
Q3
$7.89M Buy
180,340
+21,757
+14% +$1.06M 0.44% 41
2022
Q2
$8.31M Buy
158,583
+32,271
+26% +$1.64M 0.47% 34
2022
Q1
$6.54M Buy
126,312
+4,304
+4% +$223K 0.37% 50
2021
Q4
$7.21M Buy
122,008
+1,510
+1% +$74.8K 0.41% 44
2021
Q3
$5.18M Buy
120,498
+10,565
+10% +$468K 0.35% 63
2021
Q2
$4.3M Sell
109,933
-5,046
-4% -$196K 0.31% 73
2021
Q1
$4.17M Sell
114,979
-14
-0% -$497 0.37% 60
2020
Q4
$4.23M Sell
114,993
-2,290
-2% -$84K 0.48% 44
2020
Q3
$4.08M Sell
117,283
-16,033
-12% -$562K 0.55% 33
2020
Q2
$4.14M Sell
133,316
-45,684
-26% -$1.55M 0.64% 29
2020
Q1
$5.54M Buy
179,000
+7,473
+4% +$255K 1.08% 13
2019
Q4
$6.38M Buy
171,527
+5,783
+3% +$206K 1.31% 13
2019
Q3
$5.65M Buy
165,744
+13,708
+9% +$498K 0.92% 15
2019
Q2
$6.25M Sell
152,036
-13,960
-8% -$554K 1.07% 10
2019
Q1
$6.69M Buy
+165,996
New +$6.65M 1.19% 7

Other funds holding PFE

Vestmark Advisory Solutions's PFE Position: Q1 2026 in Review

Vestmark Advisory Solutions increased its Pfizer (PFE) stake by 667% in Q1 2026, buying an estimated $7.37M and bringing the position to 318,106 shares worth $8.93M. The position accounts for 0.1% of the portfolio, ranked #211.

Vestmark Advisory Solutions first reported a position in PFE in Q1 2019 and has held it in 24 quarters since. The position peaked at $9.58M in Q4 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Vestmark Advisory Solutions held 318,106 shares of Pfizer worth $8.93M as of Q1 2026.
  • Vestmark Advisory Solutions bought 276,646 Pfizer shares in Q1 2026, an estimated $7.37M.
  • Pfizer made up 0.1% of Vestmark Advisory Solutions's portfolio in Q1 2026, its #211 holding.
  • Vestmark Advisory Solutions first reported a position in Pfizer in Q1 2019 and has held it in 24 quarters since.
  • Vestmark Advisory Solutions's Pfizer position peaked at $9.58M in Q4 2022.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.